1. 173 Comparative effectiveness of secukinumab and golimumab in ankylosing spondylitis assessed by matching-adjusted indirect comparison using pivotal phase III clinical trial data. (25th April 2018) Authors: Tahir, Hasan; Maksymowych, Walter; Choy, Ernest; Yazici, Yusuf; Walsh, Jessica; Thom, Howard; Kalyvas, Chrysostomos; Fox, Todd; Gandi, Kunal; Jugl, Steffen Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 175 Comparative effectiveness of secukinumab and infliximab in psoriatic arthritis assessed by matching-adjusted indirect comparison using pivotal Phase III clinical trial data. (25th April 2018) Authors: Kaul, Arvind; Strand, Vibeke; McInnes, Iain; Mease, Philip; Choy, Ernest; Nash, Peter; Thom, Howard; Kalyvas, Chrysostomos; Gandhi, Kunal; Pricop, Luminita; Jugl, Steffen Journal: Rheumatology Issue: Volume 57(2018)Supplement 3 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Botulinum Toxins Type A (Bont-A) in the Management of Lower Limb Spasticity in Children: A Systematic Literature Review and Bayesian Network Meta-analysis. (June 2019) Authors: Guyot, Patricia; Kalyvas, Chrysostomos; Mamane, Carole; Danchenko, Natalya Journal: Journal of child neurology Issue: Volume 34:Number 7(2019:Jul.) Page Start: 371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Continuous(ly) missing outcome data in network meta-analysis: A one-stage pattern-mixture model approach. (April 2021) Authors: Spineli, Loukia M; Kalyvas, Chrysostomos; Papadimitropoulou, Katerina Journal: Statistical methods in medical research Issue: Volume 30:Number 4(2021) Page Start: 958 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritis. (26th February 2019) Authors: Strand, Vibeke; McInnes, Iain; Mease, Philip; Nash, Peter; Thom, Howard; Kalyvas, Chrysostomos; Hunger, Matthias; Gandhi, Kunal; Pricop, Luminita; Jugl, Steffen; Choy, Ernest Journal: Journal of comparative effectiveness research Issue: Volume 8:Number 7(2019) Page Start: 497 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Participants' outcomes gone missing within a network of interventions: Bayesian modeling strategies. (27th May 2019) Authors: Spineli, Loukia M.; Kalyvas, Chrysostomos; Pateras, Konstantinos Journal: Statistics in medicine Issue: Volume 38:Number 20(2019) Page Start: 3861 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Pembrolizumab+chemotherapy versus atezolizumab+chemotherapy+/−bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison. (May 2021) Authors: Halmos, Balazs; Burke, Thomas; Kalyvas, Chrysostomos; Vandormael, Kristel; Frederickson, Andrew; Piperdi, Bilal Journal: Lung cancer Issue: Volume 155(2021) Page Start: 175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Quantifying the robustness of primary analysis results: A case study on missing outcome data in pairwise and network meta‐analysis. (21st February 2021) Authors: Spineli, Loukia M.; Kalyvas, Chrysostomos; Papadimitropoulou, Katerina Journal: Research synthesis methods Issue: Volume 12:Number 4(2021) Page Start: 475 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗